Phreesia, Inc. (NYSE:PHR) Shares Bought by Graham Capital Management L.P.

Graham Capital Management L.P. boosted its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 50.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,026 shares of the company's stock after buying an additional 10,021 shares during the period. Graham Capital Management L.P. owned approximately 0.05% of Phreesia worth $755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the business. Johnson Financial Group Inc. grew its stake in Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. R Squared Ltd purchased a new stake in Phreesia during the 4th quarter valued at about $30,000. BankPlus Trust Department purchased a new stake in Phreesia during the 4th quarter valued at about $34,000. Quarry LP grew its stake in Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares during the last quarter. Finally, Venturi Wealth Management LLC purchased a new stake in Phreesia during the 4th quarter valued at about $76,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Phreesia news, CFO Balaji Gandhi sold 5,771 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $30.04, for a total transaction of $173,360.84. Following the completion of the transaction, the chief financial officer now owns 105,514 shares of the company's stock, valued at $3,169,640.56. This represents a 5.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP David Linetsky sold 4,499 shares of the stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the transaction, the senior vice president now directly owns 217,239 shares of the company's stock, valued at $5,155,081.47. The trade was a 2.03% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 55,260 shares of company stock worth $1,406,251. 5.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Canaccord Genuity Group boosted their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, March 13th. KeyCorp lowered their target price on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. DA Davidson lowered their target price on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Piper Sandler restated an "overweight" rating and issued a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Needham & Company LLC restated a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research note on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $31.33.

Phreesia Stock Performance

Shares of PHR stock opened at $26.23 on Thursday. The company has a market capitalization of $1.54 billion, a P/E ratio of -17.84 and a beta of 0.74. The business's 50 day moving average is $25.17 and its two-hundred day moving average is $24.84. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.